Activity Planners

Linda G. Baer, MSPH, CHCP
Co-Founder & COO
ECHO Diabetes Action Network
Washington, DC

Nicolas Cuttriss, MD, MPH, FAAP
Course Director
Founding Director & CEO
ECHO Diabetes Action Network
Washington, DC

Samantha Gordon, MS
Accreditation Manager 
Med-IQ
Baltimore, MD

Sara C. Miller, MS, CPHQ
Vice President, Quality Improvement and Patient Safety 
Med-IQ
Baltimore, MD

Julie White, MS, CHCP  
Director, Continuing Medical Education  Boston University School of Medicine  
Boston, MA  

Presenting Faculty 

Crystal Gadegbeku, MD, FASN  
Nephrologist   
Chair of Nephrology, Glickman Urological and Kidney Institute 
Cleveland Clinic   
Cleveland, OH
American Society of Nephrology Councilor 

Dr. Gadegbeku received grant research support from Bristol Meyers Squibb.

George Thomas, MD
Nephrologist
Glickman Urological and Kidney Institute
Cleveland Clinic
Cleveland, OH

Dr. Thomas receives grant research support from Boehringer-Ingelheim. 

The speakers do not plan on discussing the unlabeled/investigational uses of a commercial product.

Hub Faculty 

Nayan Arora, MD
Nephrologist 
Clinical Assistant Professor, Medicine 
Division of Nephrology
University of Washington 
Seattle, WA

Matthew Bouchonville, MD, CDCES
Endocrinologist 
Associate Professor, Department of Medicine 
University of New Mexico School of Medicine 
Medical Director 
UNM Diabetes Comprehensive Care Center 
UNM Center for Diabetes and Nutrition Education 
Albuquerque, NM

Kelly Close, MBA
Founder
diatribe Foundation
San Francisco, CA

Nicolas Cuttriss, MD, MPH, FAAP
Pediatric Endocrinologist 
Founding Director & CEO
ECHO Diabetes Action Network 
Washington, DC

Phyllisa Deroze, PhD
Patient Advocate 
Director of Research 
The Diabetes Research Company
Baton Rouge, LA 

Korey Hood, PhD 
Psychologist  
Professor of Pediatrics, Psychiatry and Behavioral Sciences 
Staff Psychologist 
Stanford University School of Medicine 
Palo Alto, CA

Sean Oser, MD, MPH 
Primary Care Physician 
Associate Professor, Family Medicine 
University of Colorado School of Medicine 
Denver, CO

Daniel Saltman, MD, FACP 
Internal Medicine Physician 
Associate Clinical Professor, Department of Medicine 
University of Hawaii John A. Burns School of Medicine 
Honolulu, Hawaii 

Jay H. Shubrook, DO
Primary Care Physician 
Professor
Touro University California 
Vacaville, CA 

Lisa Taylor, DNP, FNP-BC, BC-ADM, CDCES
Nurse Practitioner 
Assistant Clinical Professor 
University of New Mexico 
Albuquerque, NM

Julie Valdes, PharmD, CDCES, CTTS
Pharmacist  
Zufall Health Center 
Dover, NJ 

Disclosure Statement 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Nayan Arora, MD Consulting fees/advisory boards: George Clinical

Matthew Bouchonville, MD, CDCES has no relevant financial relationships to disclose.

Kelly Close, MBA has no relevant financial relationships to disclose.

Phyllisa Deroze, PhD has no relevant financial relationships to disclose.

Robert Gabbay, MD, PhD, FACP Consulting fees/advisory boards: Lark, Health Reveal, Vida Health, Onduo

Korey Hood, PhD  Consulting fees/advisory boards: Cecelia Health, Insulet Corporation, LifeScan Diabetes Institute 

Sean Oser, MD , MPH Consulting fees/advisory boards: Dexcom, Inc. 

Daniel Saltman, MD, FACP has no relevant financial relationships to disclose.  

Jay  H. Shubrook, DO  Consulting fees/advisory boards: Abbott, AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Eli Lilly and Company, Novo Nordisk 

Lisa Taylor, DNP, FNP-BC, BC-ADM, CDCES, CNE Nurse Advisor, has no relevant financial relationships to disclose.   

Katherine Tuttle, MD, FASN, FACP, FNKF (Presenting faculty)  Consulting fees/advisory boards: AstraZeneca, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Inc., Goldfinch Bio, Inc., Novo Nordisk

Contracted research: Bayer HealthCare Pharmaceuticals, Goldfinch Bio, Inc., Travere Therapeutics, Inc.

Julie Valdes, PharmD, CDCES, CTTS has indicated no real or apparent conflicts. 

Joseph Vassalotti, MD (Presenting faculty) Consulting fees/advisory boards: Boehringer Ingelheim, Eli Lilly and Company, Renalytix

Accreditor Disclosure 

The following planning committee members from Boston University School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships with ineligible companies:
Michael Burk, BS – Senior Program Manager

Ilana Hardesty, MLA - Assistant Director

Catherine Sullivan, MD – CME Accreditation Reviewer

All other faculty /Planning Committee /Administrators and Case Presenters have no relevant financial relationships to disclose.

Disclaimer 

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICALE DUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY AND ECHO DIABETES ACTION NETWORK MAKE NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY OR ECHO DIABETES ACTION NETWORK BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.